Pyranodipyran Derivatives with Tyrosyl DNA Phosphodiesterase 1 Inhibitory Activities and Fluorescent Properties from Aspergillus sp. EGF 15-0-3

Four new benzodipyran racemates, namely (±)-aspergiletals A-D ( - ), representing a rare pyrano[4,3- ]chromene scaffold were isolated together with eurotiumide G ( ) and eurotiumide F ( ) from the soft-coral-derived fungus sp. EGF 15-0-3. All the corresponding optically pure enantiomers were success...

Full description

Saved in:
Bibliographic Details
Published inMarine drugs Vol. 20; no. 3; p. 211
Main Authors Wei, Xia, Wang, Fang-Ting, Si-Tu, Mei-Xia, Fan, Hao, Hu, Jin-Shan, Yang, Hao, Guan, Shan-Yue, An, Lin-Kun, Zhang, Cui-Xian
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 17.03.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Four new benzodipyran racemates, namely (±)-aspergiletals A-D ( - ), representing a rare pyrano[4,3- ]chromene scaffold were isolated together with eurotiumide G ( ) and eurotiumide F ( ) from the soft-coral-derived fungus sp. EGF 15-0-3. All the corresponding optically pure enantiomers were successfully separated by a chiral HPLC column. The structures and configurations of all the compounds were elucidated based on the combination of NMR and HRESIMS data, chiral separation, single-crystal X-ray diffraction, quantum chemical C NMR, and electronic circular dichroism calculations. Meanwhile, the structure of eurotiumide G was also revised. The TDP1 inhibitor activities and photophysical properties of the obtained compounds were evaluated. In the TDP1 inhibition assay, as a result of synergy between (+)- and (-)- , (±)- displayed strong inhibitory activity to TDP1 with IC values of 6.50 ± 0.73 μM. All compounds had a large Stokes shift and could be utilized for elucidating the mode of bioactivities by fluorescence imaging.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ISSN:1660-3397
1660-3397
DOI:10.3390/md20030211